Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 127Breast Neoplasms 83Neoplasms 79Colorectal Neoplasms 68Neoplasm Metastasis 66Prostatic Neoplasms 61Leukemia, Myeloid, Acute 59Ovarian Neoplasms 58Recurrence 56Pancreatic Neoplasms 56Multiple Myeloma 51Melanoma 41Lung Neoplasms 38Glioblastoma 38Triple Negative Breast Neoplasms 36Squamous Cell Carcinoma of Head and Neck 35Endometrial Neoplasms 33Lymphoma, Non-Hodgkin 31Precursor Cell Lymphoblastic Leukemia-Lymphoma 30Lymphoma, Large B-Cell, Diffuse 28Carcinoma, Renal Cell 28Lymphoma 27Stomach Neoplasms 26Small Cell Lung Carcinoma 26Myelodysplastic Syndromes 26Carcinoma, Hepatocellular 26Lymphoma, B-Cell 25Advanced Solid Tumor 25Sarcoma 24Leukemia, Lymphocytic, Chronic, B-Cell 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Cytomegalovirus Infections × 90 days × Clear all
NCT04364178 2026-05-27

Viral Specific T-Lymphocytes to Treat Adenovirus, CMV and EBV

Stanford University

Phase 1/2 Terminated
8 enrolled 14 charts

Adenoviridae Infections, Cytomegalovirus Infections, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡